About 10% of Americans Have Genes That May Make GLP-1 Drugs Less Effective: What You Should Know

Weight loss drugs don't work for everyone—here’s why

Some people who take GLP-1 drugs such as semaglutide and tirzepatide see little to no changes to their weight. The reason why may be genetics

Comprehensive guide on weight loss using GLP-1 medications: Here’s a detailed list!

Glucagon-like peptide-1 (GLP-1) therapies have offered clinically proven weight-loss and metabolic benefits. We know that obesity is a relapsing and chronic ailment that has affected more than 1 billion individuals across the world. Hence, knowing what to do makes all the difference. What are GLP-1 agonists in brief? These are classes of medicines that are usually...

Study: Lifestyle Changes Reduce Chronic Disease Risk in Prediabetes by 21%

(NaturalNews) Key Findings: Diet, Weight Loss, Exercise Outperform MetforminA 21-year study published in JAMA found that adults with prediabetes who followed an i...

Number of Americans taking GLP-1s for weight loss hits record high: Survey

A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. According to the poll, 11 percent of Americans currently take a GLP-1 medication for weight loss, compared to just 3 percent in 2024. In addition, 15 percent...

Medication abortion: Decisions from federal courts, the FDA or Trump’s Department of Justice could try to end access via telehealth

Roughly two-thirds of Americans end their pregnancies by taking two abortion medications – misoprostol and mifepristone. Because these safe, effective medications can be prescribed via telehealth, without an in-office visit, they are how most ...

Americans reject moderation even in the use of GLP-1 drugs, as their usage has caused a spike in calls to poison control centers [Amusing]

[link] [10 comments]

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

15 of Americans have ever taken the drugs, up from 6 in 2024.

Ubiquitin-like proteins NEDD8 and SUMO2 control epithelial homeostasis, regeneration, and inflammation | Science

Stratified epithelial differentiation involves transcriptional and proteomic remodeling. Here, multiomic profiling implicated ubiquitin and related posttranslational networks in differentiation dynamics. Systematic perturbation of ubiquitin-like ...

Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know

NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans.

David Protein CEO says ‘diet trends are over’ because of GLP-1s: ‘What’s next is really hard to predict’

About 10 of the U.S. population has used GLP-1 drugs, helping to create a projected 82 billion market this year.

Women Are Getting Hired More After Losing Weight on GLP-1 Drugs: A New Study Raises Difficult Questions

A new study found GLP-1 drug users hired more after weight loss — but researchers say the finding reflects illegal-in-most-states weight discrimination, not just health gains.

Can A Single Lifestyle Change Offset Your Genetic Risk For Diabetes?

And it's not as intensive as you might think.

Are GLP-1s Performance-Enhancing Drugs?

Are GLP-1s Performance-Enhancing Drugs? (First column, 8th story, link) Drudge Report Feed needs your support! Become a Patron

GLP-1 use hits record high as Medicare opens access

According to a new Gallup survey released Tuesday, 11 percent of Americans say they’re currently taking a GLP-1, a noticeable jump from the 3 percent who said the same in 2024. Subscribe: https://www.youtube.com/ktla?sub_confirmation=1

GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds

A new Gallup survey reveals that 11 of U.S. adults currently take GLP-1 medications for weight loss, a sharp rise from just 3 in 2024. The figure climbed steadily, moving from 3 in 2024 to 8 in 2025, before reaching the current 11 recorded in the latest survey conducted in mid-2026. Gallup also found that [] The post GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds appeared first on Foreign Policy Journal.

Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.

Gynaecologist reveals the most common misconceptions about fibroids - and why 'benign' doesn't mean 'harmless'

Gynaecologist reveals the most common misconceptions about fibroids - and why 'benign' doesn't mean 'harmless'

Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence

Ivermectin isn't a cancer miracle drug, but influencers claim otherwise -- here's how to avoid sprinting past scientific evidence

Substack 7: Nutrition has a Metaverse Problem

When nutritional epidemiologists conclude (as they always do) that some item of our diet or lifestyle associates with chronic disease, it’s inevitably news. Not so when methodologists point out potential, if not very disturbing problems with the epidemiology itself. This research has enormous influence on our conceptions of a healthy diet and yet the media...Read More »

Cancer Patients Swapping Chemotherapy for Ivermectin as Oncologists Sound Alarm

A JAMA Network Open study tracking 68 million patient records found ivermectin prescriptions among cancer patients more than doubled after Mel Gibson's Joe Rogan interview. The American Society of Clinical Oncology says there is no clinical evidence the antiparasitic drug treats cancer and that its interactions with chemotherapy remain incompletely understood.

Yogurt wars: Danone-Chobani clash underscores wider protein battle

The battle for protein supremacy is particularly important in the United States, where growing numbers of GLP-1 weight loss drug users seek it out to combat muscle wastage.

My Top 5 Pharma Stocks Wall Street Ignores

My Top 5 Pharma Stocks Wall Street Ignores

CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

One company leads in gene-editing approvals, while the other targets surging demand in metabolic treatments. Here’s how their financials and risk profiles compare.

Ozempic Face, Blindness Claims, And Billions In Potential Damages: The GLP-1 Reckoning

Ozempic Lawsuits 2026 Side Effects 2B Claims Image by Radoslaw MaciejewskiShutterstock (1)A surge in demand for GLP-1 receptor agonist drugs su...

GLP-1 Debate: Kiran Mazumdar-Shaw Warns Of Long-Term Risks As Nithin Kamath Flags Weak

Biocon's executive chairperson says lifestyle changes should remain the first choice, while Zerodha's founder says generic GLP-1 uptake has lagged despite lower prices.

What is Glutathione and Why Do You Need it?

Many people ask us: What is glutathione? It may just be the most important molecule your body produces. Get the inside scoop...Click to Keep Reading »

WEGOVY THE WONDER DRUG

Lose weight, reduce the risk of CV disease – unless you are taking Wegovy? [A tale of mystery and intrigue unfolds]. A lot of people have asked me about the weight loss drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 agonists) e.g. Wegovy (semaglutide), or Mounjaro (tirzepatide). What do I think of them, are they []

Capri-Sun batches recalled after regular juice put in sugar-free packs

The FSAI says the incorrect pouch labelling may mislead consumers who need to monitor their sugar intake, including people with diabetes.

Most IVF add-ons do not improve fertility, review finds

Most IVF add-ons do not improve fertility, review finds

The Ozempic Side Effect That’s Changing America’s Morning Coffee

This article is part of Upstream, The Daily Wire’s new home for culture and lifestyle. Real human insight and human stories — from our featured writers to you. *** As the GLP-1 train keeps on rolling, the 30 million adults taking weight loss medications such as Ozempic, Wegovy, Zepbound, and Mounjaro face a serious struggle ...